169 related articles for article (PubMed ID: 35606145)
21. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.
Du H; Cline MS; Osborne RJ; Tuttle DL; Clark TA; Donohue JP; Hall MP; Shiue L; Swanson MS; Thornton CA; Ares M
Nat Struct Mol Biol; 2010 Feb; 17(2):187-93. PubMed ID: 20098426
[TBL] [Abstract][Full Text] [Related]
22. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.
Hao M; Akrami K; Wei K; De Diego C; Che N; Ku JH; Tidball J; Graves MC; Shieh PB; Chen F
Dev Dyn; 2008 Feb; 237(2):403-10. PubMed ID: 18213585
[TBL] [Abstract][Full Text] [Related]
23. An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I.
López-Martínez A; Soblechero-Martín P; de-la-Puente-Ovejero L; Nogales-Gadea G; Arechavala-Gomeza V
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32971903
[TBL] [Abstract][Full Text] [Related]
24. Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients.
Nishi M; Kimura T; Igeta M; Furuta M; Suenaga K; Matsumura T; Fujimura H; Jinnai K; Yoshikawa H
PLoS One; 2020; 15(5):e0224912. PubMed ID: 32407311
[TBL] [Abstract][Full Text] [Related]
25. Calpain-Dependent Degradation of Nucleoporins Contributes to Motor Neuron Death in a Mouse Model of Chronic Excitotoxicity.
Sugiyama K; Aida T; Nomura M; Takayanagi R; Zeilhofer HU; Tanaka K
J Neurosci; 2017 Sep; 37(36):8830-8844. PubMed ID: 28821644
[TBL] [Abstract][Full Text] [Related]
26. Muscleblind-like 2 knockout shifts adducin 1 isoform expression and alters dendritic spine dynamics of cortical neurons during brain development.
Huang CW; Lee KY; Lin PT; Nian FS; Cheng HY; Chang CH; Liao CY; Su YL; Seah C; Li C; Chen YF; Lee MH; Tsai JW
Neuropathol Appl Neurobiol; 2023 Apr; 49(2):e12890. PubMed ID: 36765387
[TBL] [Abstract][Full Text] [Related]
27. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
28. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
[TBL] [Abstract][Full Text] [Related]
29. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
30. Calpain-Mediated Degradation of Drebrin by Excitotoxicity In vitro and In vivo.
Chimura T; Launey T; Yoshida N
PLoS One; 2015; 10(4):e0125119. PubMed ID: 25905636
[TBL] [Abstract][Full Text] [Related]
31. Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.
Wojciechowska M; Taylor K; Sobczak K; Napierala M; Krzyzosiak WJ
RNA Biol; 2014; 11(6):742-54. PubMed ID: 24824895
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes.
Dastidar S; Majumdar D; Tipanee J; Singh K; Klein AF; Furling D; Chuah MK; VandenDriessche T
Mol Ther; 2022 Jan; 30(1):75-91. PubMed ID: 34371182
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1.
Todd PK; Ackall FY; Hur J; Sharma K; Paulson HL; Dowling JJ
Dis Model Mech; 2014 Jan; 7(1):143-55. PubMed ID: 24092878
[TBL] [Abstract][Full Text] [Related]
34. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.
Sobczak K; Wheeler TM; Wang W; Thornton CA
Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533
[TBL] [Abstract][Full Text] [Related]
35. Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease.
Atherton J; Kurbatskaya K; Bondulich M; Croft CL; Garwood CJ; Chhabra R; Wray S; Jeromin A; Hanger DP; Noble W
Aging Cell; 2014 Feb; 13(1):49-59. PubMed ID: 23919677
[TBL] [Abstract][Full Text] [Related]
36. Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.
López-Menéndez C; Gamir-Morralla A; Jurado-Arjona J; Higuero AM; Campanero MR; Ferrer I; Hernández F; Ávila J; Díaz-Guerra M; Iglesias T
Hum Mol Genet; 2013 Feb; 22(3):466-82. PubMed ID: 23118350
[TBL] [Abstract][Full Text] [Related]
37. Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.
Herrendorff R; Faleschini MT; Stiefvater A; Erne B; Wiktorowicz T; Kern F; Hamburger M; Potterat O; Kinter J; Sinnreich M
J Biol Chem; 2016 Aug; 291(33):17165-77. PubMed ID: 27298317
[TBL] [Abstract][Full Text] [Related]
38. Pathogenic mechanisms of myotonic dystrophy.
Lee JE; Cooper TA
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1281-6. PubMed ID: 19909263
[TBL] [Abstract][Full Text] [Related]
39. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy.
Osborne RJ; Lin X; Welle S; Sobczak K; O'Rourke JR; Swanson MS; Thornton CA
Hum Mol Genet; 2009 Apr; 18(8):1471-81. PubMed ID: 19223393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
